Publication | Open Access
Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis
71
Citations
26
References
2013
Year
The choice of LFX or MXF for treatment of patients with MDR-TB may not affect sputum culture conversion at 3 months of treatment. Clinical trial registered with www.clinicaltrials.gov (NCT 01055145).
| Year | Citations | |
|---|---|---|
Page 1
Page 1